Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- ZUMZ -16.2%, ADBE -4.1%, KR -2.9%
Other news:
- PMTS -16.9% (prices 2.34 mln-share secondary offering at $21.50/share)
- EXEL -1.8% (FDA notified Exelixis that it had extended the review period for Exelixis' new drug application (NDA) for zanzalintinib)
- HOOD -0.7% (reports August operating data)
- TENB -0.7% (prices upsized $725 mln convertible notes offering)